Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 5000IU/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 10000IU/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Sweden
Brand Name : Oncaspar
Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING
Dosage Strength : 750 IE/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Vial
Dosage Strength : 3750IU
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : USA
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN
Brand Name : RYLAZE
Dosage Form : INJECTABLE;INTRAMUSCULAR
Dosage Strength : 10MG/0.5ML
Packaging :
Approval Date :
Application Number : 761179
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ELSPAR
Dosage Form : VIAL
Dosage Strength : 10,000IU/VIAL
Packaging :
Approval Date :
Application Number : 101063
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : ASPARLAS
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 3750UNITS/5ML
Packaging :
Approval Date :
Application Number : 761102
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Brand Name : Oncaspar
Dosage Form : Dry Sub
Dosage Strength : 3750iu
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Canada
Brand Name : ONCASPAR
Dosage Form : SOLUTION
Dosage Strength : 750UNIT/ML
Packaging : 5ML
Approval Date :
Application Number : 2461900
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
Brand Name : ASPARLAS
Dosage Form : SOLUTION
Dosage Strength : 3750UNIT/5ML
Packaging :
Approval Date :
Application Number : 2542943
Regulatory Info :
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
